{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:47:17Z","timestamp":1789444037576,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:00:00Z","timestamp":1339459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/bjc.2012.236","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T20:02:11Z","timestamp":1339531331000},"page":"308-314","source":"Crossref","is-referenced-by-count":39,"title":["Normal tissues toxicities triggered by combined anti-angiogenic and radiation therapies: hurdles might be ahead"],"prefix":"10.1038","volume":"107","author":[{"given":"M","family":"Mangoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"Vozenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Biti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,12]]},"reference":[{"key":"BFbjc2012236_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1215\/15228517-2008-010","volume":"10","author":"CP Carden","year":"2008","unstructured":"Carden CP, Larkin JM, Rosenthal MA (2008) What is the risk of intracranial bleeding during anti-VEGF therapy? Neuro Oncol 10: 624\u2013630","journal-title":"Neuro Oncol"},{"key":"BFbjc2012236_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407: 249\u2013257","journal-title":"Nature"},{"key":"BFbjc2012236_CR3","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3171\/2010.10.JNS101042","volume":"114","author":"AJ Clark","year":"2011","unstructured":"Clark AJ, Butowski NA, Chang SM, Prados MD, Clarke J, Polley MY, Sughrue ME, McDermott MW, Parsa AT, Berger MS, Aghi MK (2011) Impact of bevacizumab chemotherapy on craniotomy wound healing. J Neurosurg 114: 1609\u20131616","journal-title":"J Neurosurg"},{"key":"BFbjc2012236_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.vascn.2007.08.002","volume":"57","author":"JB Cornacoff","year":"2008","unstructured":"Cornacoff JB, Howk K, Pikounis B, Mendenhall V, Martin P (2008) Development of a method for the evaluation of wound tensile strength in cynomolgus macaques. J Pharmacol Toxicol Methods 57: 74\u201379","journal-title":"J Pharmacol Toxicol Methods"},{"key":"BFbjc2012236_CR5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1200\/JCO.2005.03.6780","volume":"24","author":"CH Crane","year":"2006","unstructured":"Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA (2006) Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol 24: 1145\u20131151","journal-title":"J Clin Oncol"},{"key":"BFbjc2012236_CR6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jso.21447","volume":"101","author":"I Deshaies","year":"2010","unstructured":"Deshaies I, Malka D, Soria JC, Massard C, Bahleda R, Elias D (2010) Antiangiogenic agents and late anastomotic complications. J Surg Oncol 101: 180\u2013183","journal-title":"J Surg Oncol"},{"key":"BFbjc2012236_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/ncponc0295","volume":"2","author":"E Deutsch","year":"2005","unstructured":"Deutsch E, Soria JC, Armand JP (2005) New concepts for phase I trials: evaluating new drugs combined with radiation therapy. Nat Clin Pract Oncol 2: 456\u2013465","journal-title":"Nat Clin Pract Oncol"},{"key":"BFbjc2012236_CR8","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/cncr.25573","volume":"117","author":"JP Erinjeri","year":"2011","unstructured":"Erinjeri JP, Fong AJ, Kemeny NE, Brown KT, Getrajdman GI, Solomon SB (2011) Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement. Cancer 117: 1296\u20131301","journal-title":"Cancer"},{"key":"BFbjc2012236_CR9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/0008-5472.671.65.3","volume":"65","author":"HP Gerber","year":"2005","unstructured":"Gerber HP, Ferrara N (2005) Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. Cancer Res 65: 671\u2013680","journal-title":"Cancer Res"},{"key":"BFbjc2012236_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijrobp.2006.10.010","volume":"67","author":"J Gonzalez","year":"2007","unstructured":"Gonzalez J, Kumar AJ, Conrad CA, Levin VA (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67: 323\u2013326","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFbjc2012236_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijrobp.2008.10.043","volume":"75","author":"PH Gutin","year":"2009","unstructured":"Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL, Lymberis S, Yamada Y, Chang J, Abrey LE (2009) Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 75: 156\u2013163","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFbjc2012236_CR12","first-page":"5286","volume":"57","author":"CK Haston","year":"1997","unstructured":"Haston CK, Travis EL (1997) Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res 57: 5286\u20135291","journal-title":"Cancer Res"},{"key":"BFbjc2012236_CR13","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1046\/j.1365-2168.1999.01223.x","volume":"86","author":"JM Hendriks","year":"1999","unstructured":"Hendriks JM, Hubens G, Wuyts FL, Vermeulen P, Hubens A, Eyskens E (1999) Experimental study of intraperitoneal suramin on the healing of colonic anastomoses. Br J Surg 86: 1171\u20131175","journal-title":"Br J Surg"},{"key":"BFbjc2012236_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1006\/jsre.2001.6089","volume":"96","author":"TR Howdieshell","year":"2001","unstructured":"Howdieshell TR, Callaway D, Webb WL, Gaines MD, Procter CD, Sathyanarayana, Pollock JS, Brock TL, McNeil PL (2001) Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res 96: 173\u2013182","journal-title":"J Surg Res"},{"key":"BFbjc2012236_CR15","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335\u20132342","journal-title":"N Engl J Med"},{"key":"BFbjc2012236_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307: 58\u201362","journal-title":"Science"},{"key":"BFbjc2012236_CR17","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1200\/JCO.2010.31.4815","volume":"29","author":"DS Jeyaretna","year":"2011","unstructured":"Jeyaretna DS, Curry WT, Batchelor TT, Stemmer-Rachamimov A, Plotkin SR (2011) Exacerbation of cerebral radiation necrosis by bevacizumab. J Clin Oncol 29: e159\u2013e162","journal-title":"J Clin Oncol"},{"key":"BFbjc2012236_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1200\/JCO.2003.10.066","volume":"21","author":"F Kabbinavar","year":"2003","unstructured":"Kabbinavar F, Hurwitz HI, Fehrenbacher L, Meropol NJ, Novotny WF, Lieberman G, Griffing S, Bergsland E (2003) Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)\/leucovorin (LV) with FU\/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 21: 60\u201365","journal-title":"J Clin Oncol"},{"key":"BFbjc2012236_CR19","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1200\/JCO.2005.05.112","volume":"23","author":"FF Kabbinavar","year":"2005","unstructured":"Kabbinavar FF, Schulz J, McCleod M, Patel T, Hamm JT, Hecht JR, Mass R, Perrou B, Nelson B, Novotny WF (2005) Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 23: 3697\u20133705","journal-title":"J Clin Oncol"},{"key":"BFbjc2012236_CR20","first-page":"4285","volume":"21","author":"MI Koukourakis","year":"2001","unstructured":"Koukourakis MI (2001) Tumour angiogenesis and response to radiotherapy. Anticancer Res 21: 4285\u20134300","journal-title":"Anticancer Res"},{"key":"BFbjc2012236_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.2010.30.2729","volume":"29","author":"A Lai","year":"2011","unstructured":"Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, Phuphanich S, Black K, Peak S, Green RM, Spier CE, Kolevska T, Polikoff J, Fehrenbacher L, Elashoff R, Cloughesy T (2011) Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 29: 142\u2013148","journal-title":"J Clin Oncol"},{"key":"BFbjc2012236_CR22","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","volume":"79","author":"VA Levin","year":"2011","unstructured":"Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Prabhu S, Loghin M, Gilbert MR, Jackson EF (2011) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 79: 1487\u20131495","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFbjc2012236_CR23","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1200\/JCO.2011.38.4552","volume":"30","author":"JSW Lind","year":"2012","unstructured":"Lind JSW, Senan S, Smit EF (2012) Pulmonary toxicity after bevacizumab and concurrent thoracic radiotherapy observed in a phase I study for inoperabile stage III non-small-cell lung cancer. J Clin Oncol 30: e104\u2013e108","journal-title":"J Clin Oncol"},{"key":"BFbjc2012236_CR24","first-page":"531","volume":"100","author":"JF Llena","year":"1976","unstructured":"Llena JF, Cespedes G, Hirano A, Zimmerman HM, Feiring EH, Fine D (1976) Vascular alterations in delayed radiation necrosis of the brain. An electron microscopical study. Arch Pathol Lab Med 100: 531\u2013534","journal-title":"Arch Pathol Lab Med"},{"key":"BFbjc2012236_CR25","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.ijrobp.2005.12.004","volume":"64","author":"F Lordick","year":"2006","unstructured":"Lordick F, Geinitz H, Theisen J, Sendler A, Sarbia M (2006) Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: report of three cases. Int J Radiat Oncol Biol Phys 64: 1295\u20131298","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"BFbjc2012236_CR26","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.2174\/1389450111009011395","volume":"11","author":"V Monceau","year":"2010","unstructured":"Monceau V, Pasinetti N, Schupp C, Pouzoulet F, Opolon P, Vozenin MC (2010) Modulation of the Rho\/ROCK pathway in heart and lung after thorax irradiation reveals targets to improve normal tissue toxicity. Curr Drug Targets 11 (11): 1395\u20131404","journal-title":"Curr Drug Targets"},{"key":"BFbjc2012236_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0167-8140(83)80018-8","volume":"1","author":"CS Parkins","year":"1983","unstructured":"Parkins CS, Fowler JF, Yu S (1983) A murine model of lip epidermal\/mucosal reactions to X-irradiation. Radiother Oncol 1: 159\u2013165","journal-title":"Radiother Oncol"},{"key":"BFbjc2012236_CR28","first-page":"2679","volume":"31","author":"K Pietzner","year":"2011","unstructured":"Pietzner K, Richter R, Chekerov R, Erol E, Oskay-Ozcelik G, Lichtenegger W, Sehouli J (2011) Bevacizumab in heavily pre-treated and platinum resistant ovarian cancer: a retrospective study of the North-Eastern German Society of Gynaecologic Oncology (NOGGO) Ovarian Cancer Study Group. Anticancer Res 31: 2679\u20132682","journal-title":"Anticancer Res"},{"key":"BFbjc2012236_CR29","first-page":"499a","volume":"17","author":"P Scalliet","year":"1998","unstructured":"Scalliet P, Goor C, Galdermans D, Van Meerbeck J, Groen H, Van de Leest A (1998) Gemzar\u00ae (gemcitabine) with thoracic radiotherapy - a phase II pilot study in chemonaive patients with advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 17: 499a","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BFbjc2012236_CR30","first-page":"15","volume":"15","author":"F Schiffele","year":"2002","unstructured":"Schiffele F, Fuss IJ (2002) Induction of TNBS colitis in mice. Curr Protoc Immunol 15: 15\u201319","journal-title":"Curr Protoc Immunol"},{"key":"BFbjc2012236_CR31","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1200\/JCO.2007.13.1706","volume":"26","author":"TY Seiwert","year":"2008","unstructured":"Seiwert TY, Haraf DJ, Cohen EE, Stenson K, Witt ME, Dekker A, Kocherginsky M, Weichselbaum RR, Chen HX, Vokes EE (2008) Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer. J Clin Oncol 26: 1732\u20131741","journal-title":"J Clin Oncol"},{"key":"BFbjc2012236_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1200\/JCO.2009.24.7353","volume":"28","author":"DR Spigel","year":"2010","unstructured":"Spigel DR, Hainsworth JD, Yardley DA, Raefsky E, Patton J, Peacock N, Farley C, Burris HA, Greco FA (2010) Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab. J Clin Oncol 28: 43\u201348","journal-title":"J Clin Oncol"},{"key":"BFbjc2012236_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1245\/aso.2002.9.3.303","volume":"9","author":"EA te Velde","year":"2002","unstructured":"te Velde EA, Voest EE, van Gorp JM, Verheem A, Hagendoorn J, Gebbink MF, Borel Rinkes IH (2002) Adverse effects of the antiangiogenic agent angiostatin on the healing of experimental colonic anastomoses. Ann Surg Oncol 9: 303\u2013309","journal-title":"Ann Surg Oncol"},{"key":"BFbjc2012236_CR34","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1200\/JCO.2007.11.6566","volume":"26","author":"G Van Buren","year":"2008","unstructured":"Van Buren G, Yang AD, Dallas NA, Gray MJ, Lim SJ, Xia L, Fan F, Somcio R, Wu Y, Hicklin DJ, Ellis LM (2008) Effect of molecular therapeutics on liver regeneration in a murine model. J Clin Oncol 26: 1836\u20131842","journal-title":"J Clin Oncol"},{"key":"BFbjc2012236_CR35","doi-asserted-by":"publisher","first-page":"8136","DOI":"10.1200\/JCO.2005.02.5635","volume":"23","author":"CG Willett","year":"2005","unstructured":"Willett CG, Boucher Y, Duda DG, di Tomaso E, Munn LL, Tong RT, Kozin SV, Petit L, Jain RK, Chung DC, Sahani DV, Kalva SP, Cohen KS, Scadden DT, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Shellito PC, Mino-Kenudson M, Lauwers GY (2005) Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol 23: 8136\u20138139","journal-title":"J Clin Oncol"},{"key":"BFbjc2012236_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/09553007014550291","volume":"17","author":"HR Withers","year":"1970","unstructured":"Withers HR, Elkind MM (1970) Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol Relat Stud Phys Chem Med 17: 261\u2013267","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"key":"BFbjc2012236_CR37","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1200\/JCO.2008.19.1866","volume":"26","author":"ET Wong","year":"2008","unstructured":"Wong ET, Huberman M, Lu XQ, Mahadevan A (2008) Bevacizumab reverses cerebral radiation necrosis. J Clin Oncol 26: 5649\u20135650","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2012236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012236","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T09:25:10Z","timestamp":1687512310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2012236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,12]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFbjc2012236"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.236","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,12]]}}}